284 related articles for article (PubMed ID: 11724829)
1. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
[TBL] [Abstract][Full Text] [Related]
2. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.
Meletiadis J; Mouton JW; Meis JF; Bouman BA; Verweij PE
J Clin Microbiol; 2002 Aug; 40(8):2876-85. PubMed ID: 12149345
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
6. Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.
Hawser SP; Jessup C; Vitullo J; Ghannoum MA
J Clin Microbiol; 2001 Jul; 39(7):2738-41. PubMed ID: 11427611
[TBL] [Abstract][Full Text] [Related]
7. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Lewis RE; Wiederhold NP; Klepser ME
Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
[TBL] [Abstract][Full Text] [Related]
9. Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly JP; Verweij PE;
J Clin Microbiol; 2001 Sep; 39(9):3402-8. PubMed ID: 11526191
[TBL] [Abstract][Full Text] [Related]
10. Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
Balajee SA; Imhof A; Gribskov JL; Marr KA
J Antimicrob Chemother; 2005 Jan; 55(1):102-5. PubMed ID: 15546970
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
Yekutiel A; Shalit I; Shadkchan Y; Osherov N
Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of 2,3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) and 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) rapid colorimetric assays for antimicrobial susceptibility testing of staphylococci and ESBL-producing clinical isolates.
Brady AJ; Kearney P; Tunney MM
J Microbiol Methods; 2007 Dec; 71(3):305-11. PubMed ID: 17963904
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Shehata AS; Mukherjee PK; Ghannoum MA
J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
16. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
Carrillo-Muñoz AJ; Quindós G; Ruesga M; Brió S; del Valle O; Rodríguez V; Hernández-Molina JM; Cantón E; Pemán J; Santos P
Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
[TBL] [Abstract][Full Text] [Related]
18. Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
J Antimicrob Chemother; 2007 Feb; 59(2):230-7. PubMed ID: 17185296
[TBL] [Abstract][Full Text] [Related]
19. Rapid susceptibility testing of medically important zygomycetes by XTT assay.
Antachopoulos C; Meletiadis J; Roilides E; Sein T; Walsh TJ
J Clin Microbiol; 2006 Feb; 44(2):553-60. PubMed ID: 16455912
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
